“…In recent years several anti-inflammatory drugs such as baicalin [15], methotrexate [16], naringenin [17], resveratrol [18,19], and naproxen sodium [20] have been encapsulated in ultradeformable liposomes in order to reduce skin inflammation. The current study was focused on the co-encapsulation of two active compounds, naproxen sodium and idebenone, within ultradeformable liposomes, made up of two different edge activators, i.e., Tween ® 80 (T80), a hydrophilic non-ionic surfactant, and sodium deoxycholate (SDC), a steroid-like anionic surfactant (Formulations 1 and 2, respectively) in order to obtain a synergistic action and thus to potentiate the anti-inflammatory effect.…”